-
Exyte and Univercells Technologies to deploy vaccine production plants
expresspharma
May 15, 2020
The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the COVID-19 pandemic.
-
Coronavirus vaccine possible in about a year, says EU agency
expresspharma
May 15, 2020
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so beginning of 2021," said Marco Cavaleri, head of vaccines, European Medicines Agency.
-
Sanofi says its COVID-19 vaccine will available in all countries
expresspharma
May 15, 2020
The statement comes after the French government took objection to Sanofi CEO’s comment that the US will get first access to the company’s vaccine.
-
Exyte and Univercells Join Forces
contractpharma
May 15, 2020
Partner for rapid deployment of vaccine production plants in the wake of the COVID-19 crisis.
-
India calls upon G-20 nations to ensure access to essential medicines, treatments and vaccines at af
expresspharma
May 15, 2020
India’s Commerce Minister, in G-20 Trade Ministers meeting, informed that India has unconditionally provided medical supplies to over 120 countries to combat COVID-19.
-
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants
Univercells Technologies
May 14, 2020
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
-
USP Launches Trust Accelerated Program to Help COVID-19 Treatment, Vaccine Development
americanpharmaceuticalreview
May 14, 2020
To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
-
ZYUS, VIDO-InterVac collaborate to develop plant-based vaccine for Covid-19 disease
pharmaceutical-business-review
May 12, 2020
ZYUS Life Sciences has collaborated with University of Saskatchewan’s Vaccine and Infectious Disease Organisation-International Vaccine Centre (VIDO-InterVac) for the development of a plant-based vaccine for Covid-19 disease.
-
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,
expresspharma
May 12, 2020
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.
-
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
americanpharmaceuticalreview
May 11, 2020
OSE Immunotherapeutics announced its team of immunologists is actively working on the development of a prophylactic vaccine against the pandemic virus SARS-CoV-2.